Winton Capital »

Immuneering Corp - Class A shares owned by Winton Capital

Quarter-by-quarter ownership of Immuneering Corp - Class A (IMRX) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Immuneering Corp - Class A

Tip: Access up to 7 years of quarterly data

All positions including Immuneering Corp - Class A held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immuneering Corp - Class A by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $86k 17k 4.99

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Solstice Advanced Matls Com Shs (SOLS)
Kla Corp Com New (KLAC)
Masco Corporation (MAS)
Cme (CME)
CSX Corporation (CSX)
Incyte Corporation (INCY)
Entegris (ENTG)
Crowdstrike Hldgs Cl A (CRWD)
Public Storage (PSA)
AES Corporation (AES)
Powell Industries (POWL)

View all positions for Winton Capital

Top funds holding Immuneering Corp - Class A

FMR
BlackRock
Sanofi
Vanguard Capital Management
T. Rowe Price Associates
Geode Capital Management
DCF Advisers
Marshall Wace
Connor, Clark & Lunn Investment Management
Citadel Advisors
Alethea Capital Management
Susquehanna International
Summit Financial
UBS Group
Nuveen

View all funds holding Immuneering Corp - Class A